{
    "messages": [
        {
            "role": "system",
            "content": "\nYou are a helpful biological data assistant assigned with the task of constructing specialized biological dataset and biological data processing.\nTo achieve this, you will be using an interactive coding environment equipped with a variety of tool functions, data, and softwares to assist you throughout the process.\n\nGiven a task, make a plan first. The plan should be a numbered list of steps that you will take to solve the task. Be specific and detailed.\nFormat your plan as a checklist with empty checkboxes like this:\n1. [ ] First step\n2. [ ] Second step\n3. [ ] Third step\n\nFollow the plan step by step. After completing each step, update the checklist by replacing the empty checkbox with a checkmark:\n1. [\u2713] First step (completed)\n2. [ ] Second step\n3. [ ] Third step\n\nIf a step fails or needs modification, mark it with an X and explain why:\n1. [\u2713] First step (completed)\n2. [\u2717] Second step (failed because...)\n3. [ ] Modified second step\n4. [ ] Third step\n\nAlways show the updated plan after each step so the user can track progress.\n\nAt each turn, you should first provide your thinking and reasoning given the conversation history.\nAfter that, you have two options:\n\n1) Interact with a programming environment. Your code should be enclosed using \"<execute>\" tag, for example: <execute> print(\"Hello World!\") </execute>. IMPORTANT: You must end the code block with </execute> tag.\n   - For Python code (default): <execute> print(\"Hello World!\") </execute>\n   - For R code: <execute> #!R\nlibrary(ggplot2)\nprint(\"Hello from R\") </execute>\n   - For Bash scripts and commands: <execute> #!BASH\necho \"Hello from Bash\"\nls -la </execute>\n   - For CLI softwares, use Bash scripts.\n   \n2) When you think it is ready, directly provide a solution that adheres to the required format for the given task to the user. Your solution should be enclosed using \"<solution>\" tag, for example: The answer is <solution> A </solution>. IMPORTANT: You must end the solution block with </solution> tag.\n\nYou can only chose one option one time.\n\nYou have many chances to interact with the environment to receive the observation. So you can decompose your code into multiple steps.\nDon't overcomplicate the code. Keep it simple and easy to understand.\nWhen writing the code, please print out the steps and results in a clear and concise manner, like a research log.\nWhen calling the existing python functions in the function dictionary, YOU MUST SAVE THE OUTPUT and PRINT OUT the result.\nFor example, result = understand_scRNA(XXX) print(result)\nOtherwise the system will not be able to know what has been done.\n\nFor R code, use the #!R marker at the beginning of your code block to indicate it's R code.\nFor Bash scripts and commands, use the #!BASH marker at the beginning of your code block. This allows for both simple commands and multi-line scripts with variables, loops, conditionals, loops, and other Bash features.\n\nIn each response, you must include EITHER <execute> or <solution> tag. Not both at the same time. Do not respond with messages without any tags. No empty messages.\n\nYou could finish the task based on current environment and you must not install new version packges as it will destory the environment !!!\nYou could finish the task based on current environment and you must not install new version packges as it will destory the environment !!!\nYou could finish the task based on current environment and you must not install new version packges as it will destory the environment !!!\n\n\n\nEnvironment Resources:\n\n- Function Dictionary:\nBased on your query, I've identified the following most relevant functions that you can use in your code:\n---\nImport file: assistant.tool_biodatalab.support_tools\n====================================================\nMethod: read_function_source_code\n  Description: Read the source code of a function from any module path.\n  Required Parameters:\n    - function_name (str): Fully qualified function name (e.g., 'bioagentos.tool.support_tools.write_python_code') [Default: None]\n\n\n---\n\nIMPORTANT: When using any function, you MUST first import it from its module. For example:\nfrom [module_name] import [function_name]\n\n- Biological data lake\nYou can access a biological data lake at the following path: ./operation_env/database_lake.\nBased on your query, I've identified the following most relevant datasets:\nEach item is listed with its description to help you understand its contents.\n----\n\n----\n\n- Software Library:\nBased on your query, I've identified the following most relevant libraries that you can use:\nEach library is listed with its description to help you understand its functionality.\n----\npdfplumber:\n  [Python Package] Plumb a PDF for detailed information about each text character,\n  rectangle, and line (Essential for reading papers).\npytesseract:\n  [Python Package] Python-tesseract is an optical character recognition (OCR) tool\n  for python.\npillow:\n  [Python Package] The Python Imaging Library adds image processing capabilities\n  to your Python interpreter.\nlangchain: [Python Package] Building applications with LLMs through composability.\ntransformers:\n  [Python Package] State-of-the-art Machine Learning for Pytorch, TensorFlow, and\n  JAX.\nopenai: [Python Package] The OpenAI Python library.\nanthropic: [Python Package] The Anthropic Python library.\ngoogle-genai: [Python Package] Google Generative AI SDK.\n----\n\n- Note on using R packages and Bash scripts:\n  - R packages: Use subprocess.run(['Rscript', '-e', 'your R code here']) in Python, or use the #!R marker in your execute block.\n  - Bash scripts and commands: Use the #!BASH marker in your execute block for both simple commands and complex shell scripts with variables, loops, conditionals, etc.\n        "
        },
        {
            "role": "user",
            "content": "# Core Task\nExtract detailed pharmacological information about Antibody-Drug Conjugates (ADCs) from the literature, specifically identifying Key fields including ADC Name, Conjugate Type, Drug-Antibody Ratio (DAR), mAb, Linker, Payload, and Drug Status.\nLiterature to analyze: `dataset/ADCdb/ref2.pdf`, `dataset/ADCdb/ref4.pdf`, `dataset/ADCdb/ref5.pdf`\n\n# Output Requirements & File Path\n- Output format: A CSV file with the following columns (exactly matching the ground truth CSV headers). Use \"N/A\" for missing values.\n  - `Paper`: The reference ID or filename of the paper (e.g., ref1).\n  - `ADC Name`: The name of the Antibody-Drug Conjugate.\n  - `mAb`: The specific monoclonal antibody used.\n  - `Linker`: The type of linker used to connect the antibody and payload.\n  - `Payload`: The cytotoxic payload delivered by the ADC.\n  - `Conjugate Type`: The method or type of conjugation.\n  - `DAR`: The Drug-Antibody Ratio.\n  - `Drug Status`: The current clinical or development status of the ADC.\n- Save Path: Save the result to: `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv`\n- Intermediate Storage Path: All intermediate code generated during execution, downloaded files, and temporary results must be stored in `/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/`\n\n# Output Example (For Reference Only)\nPaper,ADC Name,mAb,Linker,Payload,Conjugate Type,DAR,Drug Status\nref2,Pseudo-ADC-X,Anti-Target-Y IgG1,Enzymatic linker,Cytotoxin Z,Site-specific,3.8,Phase 3\nref4,NextGen-ADC,Bispecific mAb,pH-sensitive linker,Potent Payload A,Cysteine conjugation,N/A,Preclinical\n"
        },
        {
            "role": "assistant",
            "content": "I will start by creating a plan to extract the required information from the specified PDF files and save it to the desired CSV format.\n\n### Plan\n1. [ ] Create the temporary directory `/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/` and the output directory `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/` if they don't exist.\n2. [ ] Verify the existence of the input PDF files (`dataset/ADCdb/ref2.pdf`, `dataset/ADCdb/ref4.pdf`, `dataset/ADCdb/ref5.pdf`).\n3. [ ] Extract text from each PDF file (`ref2.pdf`, `ref4.pdf`, `ref5.pdf`) using `pdfplumber`.\n4. [ ] Analyze the extracted text for each file to identify the required fields: `ADC Name`, `mAb`, `Linker`, `Payload`, `Conjugate Type`, `DAR`, `Drug Status`. I will use simple keyword matching or regex first, and if that is insufficient, I will try to structure the extraction logic better based on the text content (e.g., looking for tables or specific sections). Since I don't have an LLM tool in the function dictionary to parse the text directly, I will perform a keyword-based extraction and print the text to manually refine the extraction logic if needed, or implement a heuristic rule-based extraction script.\n5. [ ] Consolidate the extracted data into a pandas DataFrame.\n6. [ ] Save the DataFrame as a CSV file to `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv`.\n\nLet's start by setting up the directories and checking the files.\n\n<execute>\n#!BASH\nmkdir -p /root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/\nmkdir -p /root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/\n\nls -l dataset/ADCdb/ref2.pdf dataset/ADCdb/ref4.pdf dataset/ADCdb/ref5.pdf</execute>"
        },
        {
            "role": "user",
            "content": "<observation>Error running Bash script (exit code 2):\nls: cannot access 'dataset/ADCdb/ref2.pdf': No such file or directory\nls: cannot access 'dataset/ADCdb/ref4.pdf': No such file or directory\nls: cannot access 'dataset/ADCdb/ref5.pdf': No such file or directory\n</observation>"
        },
        {
            "role": "assistant",
            "content": "I will search for the PDF files to locate them correctly.\n\n<execute>\n#!BASH\nfind . -name \"ref2.pdf\"\nfind . -name \"ref4.pdf\"\nfind . -name \"ref5.pdf\"\nls -R dataset/ADCdb</execute>"
        },
        {
            "role": "user",
            "content": "<observation>Error running Bash script (exit code 2):\nls: cannot access 'dataset/ADCdb': No such file or directory\n</observation>"
        },
        {
            "role": "assistant",
            "content": "I will list the current directory and search for the `ADCdb` directory or the specific files.\n\n<execute>\n#!BASH\nls -F\nls -F operation_env/database_lake\nfind . -name \"ref2.pdf\"\nfind . -type d -name \"ADCdb\"</execute>"
        },
        {
            "role": "user",
            "content": "<observation>Error running Bash script (exit code 2):\nls: cannot access 'operation_env/database_lake': No such file or directory\n</observation>"
        },
        {
            "role": "assistant",
            "content": "I will list the contents of the current directory to locate the dataset.\n\n<execute>\n#!BASH\nls -R</execute>"
        },
        {
            "role": "user",
            "content": "<observation>The output is too long to be added to context. Here are the first 10K characters...\n.:\nANARCI\nREADME.md\nassistant\nbenchmark\ncache\ndata\nelton_birds_species_list.csv\nenv_install.sh\nenvironment.yaml\nenvironment.yml\nevaluate_bash_scripts\nevaluate_results\nexample_log_trajectory.json\nexample_log_trajectory_zjt.json\nexpression_analyses\nlog\nmapper_logs\nncbi_dataset.zip\noperation_env\npaper_analysis\npdfs_mysample\npdfs_sample\npred_results\nrun_evaluate_batch_biomni.py\nrun_evaluate_batch_biomni.sh\nrun_evaluate_batch_biomni_for_bash.py\nrun_evaluate_case_biomni.py\nrun_evaluate_case_stella.py\nrun_evaluate_case_tooluniverse.py\nrun_only_evaluate.py\nsample_metadata_extracted.csv\ntraitdata\n\n./ANARCI:\nExample_scripts_and_sequences\nINSTALL\nLICENCE\nLICENCE_MUSCLE\nREADME.md\nanarci.egg-info\nbin\nbuild\nbuild_pipeline\nlib\nrequirements.txt\nsetup.py\n\n./ANARCI/Example_scripts_and_sequences:\n12e8.fasta\nImmunoPDB.py\nanarci_API_example.py\nantibody_sequences.fasta\nlysozyme.fasta\npdb_sequences.fa.txt.gz\nrun_numbering_benchmark.sh\n\n./ANARCI/anarci.egg-info:\nPKG-INFO\nSOURCES.txt\ndependency_links.txt\ntop_level.txt\n\n./ANARCI/bin:\nANARCI\nmuscle\nmuscle_macOS\n\n./ANARCI/build:\nbdist.linux-x86_64\nlib\nscripts-3.11\n\n./ANARCI/build/bdist.linux-x86_64:\nwheel\n\n./ANARCI/build/bdist.linux-x86_64/wheel:\nanarci\nanarci-1.3-py3.11.egg-info\nanarci-1.3.data\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci:\n__init__.py\nanarci.py\nschemes.py\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci-1.3-py3.11.egg-info:\nPKG-INFO\nSOURCES.txt\ndependency_links.txt\ntop_level.txt\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci-1.3.data:\ndata\nscripts\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci-1.3.data/data:\nbin\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci-1.3.data/data/bin:\nANARCI\nmuscle\nmuscle_macOS\n\n./ANARCI/build/bdist.linux-x86_64/wheel/anarci-1.3.data/scripts:\nANARCI\n\n./ANARCI/build/lib:\nanarci\n\n./ANARCI/build/lib/anarci:\n__init__.py\nanarci.py\nschemes.py\n\n./ANARCI/build/scripts-3.11:\nANARCI\n\n./ANARCI/build_pipeline:\nFastaIO.py\nFastaIO.pyc\nFormatAlignments.py\nHMMs\nIMGT_sequence_files\nRUN_pipeline.sh\nRipIMGT.py\n__init__.py\n__pycache__\ncurated_alignments\nmuscle_alignments\ntest.csv_H.csv\n\n./ANARCI/build_pipeline/HMMs:\nALL.hmm\nALL.hmm.h3f\nALL.hmm.h3i\nALL.hmm.h3m\nALL.hmm.h3p\n\n./ANARCI/build_pipeline/IMGT_sequence_files:\nfastafiles\nhtmlfiles\n\n./ANARCI/build_pipeline/IMGT_sequence_files/fastafiles:\nBos_taurus_HJ.fasta\nBos_taurus_HV.fasta\nBos_taurus_KJ.fasta\nBos_taurus_KV.fasta\nBos_taurus_LJ.fasta\nBos_taurus_LV.fasta\nHomo_sapiens_AJ.fasta\nHomo_sapiens_AV.fasta\nHomo_sapiens_BJ.fasta\nHomo_sapiens_BV.fasta\nHomo_sapiens_DJ.fasta\nHomo_sapiens_DV.fasta\nHomo_sapiens_GJ.fasta\nHomo_sapiens_GV.fasta\nHomo_sapiens_HJ.fasta\nHomo_sapiens_HV.fasta\nHomo_sapiens_KJ.fasta\nHomo_sapiens_KV.fasta\nHomo_sapiens_LJ.fasta\nHomo_sapiens_LV.fasta\nMacaca_mulatta_HJ.fasta\nMacaca_mulatta_HV.fasta\nMacaca_mulatta_KJ.fasta\nMacaca_mulatta_KV.fasta\nMacaca_mulatta_LJ.fasta\nMacaca_mulatta_LV.fasta\nMus_AJ.fasta\nMus_AV.fasta\nMus_BJ.fasta\nMus_BV.fasta\nMus_DJ.fasta\nMus_DV.fasta\nMus_GJ.fasta\nMus_GV.fasta\nMus_HJ.fasta\nMus_HV.fasta\nMus_KJ.fasta\nMus_KV.fasta\nMus_LJ.fasta\nMus_LV.fasta\nOryctolagus_cuniculus_HJ.fasta\nOryctolagus_cuniculus_HV.fasta\nOryctolagus_cuniculus_KJ.fasta\nOryctolagus_cuniculus_KV.fasta\nOryctolagus_cuniculus_LJ.fasta\nOryctolagus_cuniculus_LV.fasta\nRattus_norvegicus_HJ.fasta\nRattus_norvegicus_HV.fasta\nRattus_norvegicus_KJ.fasta\nRattus_norvegicus_KV.fasta\nRattus_norvegicus_LJ.fasta\nRattus_norvegicus_LV.fasta\nSus_scrofa_HJ.fasta\nSus_scrofa_HV.fasta\nSus_scrofa_KJ.fasta\nSus_scrofa_KV.fasta\nSus_scrofa_LJ.fasta\nSus_scrofa_LV.fasta\nVicugna_pacos_HJ.fasta\nVicugna_pacos_HV.fasta\n\n./ANARCI/build_pipeline/IMGT_sequence_files/htmlfiles:\nBos_taurus_HJ.html\nBos_taurus_HV.html\nBos_taurus_KJ.html\nBos_taurus_KV.html\nBos_taurus_LJ.html\nBos_taurus_LV.html\nHomo_sapiens_AJ.html\nHomo_sapiens_AV.html\nHomo_sapiens_BJ.html\nHomo_sapiens_BV.html\nHomo_sapiens_DJ.html\nHomo_sapiens_DV.html\nHomo_sapiens_GJ.html\nHomo_sapiens_GV.html\nHomo_sapiens_HJ.html\nHomo_sapiens_HV.html\nHomo_sapiens_KJ.html\nHomo_sapiens_KV.html\nHomo_sapiens_LJ.html\nHomo_sapiens_LV.html\nMacaca_mulatta_HJ.html\nMacaca_mulatta_HV.html\nMacaca_mulatta_KJ.html\nMacaca_mulatta_KV.html\nMacaca_mulatta_LJ.html\nMacaca_mulatta_LV.html\nMus_AJ.html\nMus_AV.html\nMus_BJ.html\nMus_BV.html\nMus_DJ.html\nMus_DV.html\nMus_GJ.html\nMus_GV.html\nMus_HJ.html\nMus_HV.html\nMus_KJ.html\nMus_KV.html\nMus_LJ.html\nMus_LV.html\nOryctolagus_cuniculus_HJ.html\nOryctolagus_cuniculus_HV.html\nOryctolagus_cuniculus_KJ.html\nOryctolagus_cuniculus_KV.html\nOryctolagus_cuniculus_LJ.html\nOryctolagus_cuniculus_LV.html\nRattus_norvegicus_HJ.html\nRattus_norvegicus_HV.html\nRattus_norvegicus_KJ.html\nRattus_norvegicus_KV.html\nRattus_norvegicus_LJ.html\nRattus_norvegicus_LV.html\nSus_scrofa_HJ.html\nSus_scrofa_HV.html\nSus_scrofa_KJ.html\nSus_scrofa_KV.html\nSus_scrofa_LJ.html\nSus_scrofa_LV.html\nVicugna_pacos_HJ.html\nVicugna_pacos_HV.html\n\n./ANARCI/build_pipeline/__pycache__:\nFastaIO.cpython-311.pyc\n\n./ANARCI/build_pipeline/curated_alignments:\nALL.stockholm\nalpaca_H.stockholm\ncow_H.stockholm\ncow_K.stockholm\ncow_L.stockholm\ngermlines.py\nhuman_A.stockholm\nhuman_B.stockholm\nhuman_D.stockholm\nhuman_G.stockholm\nhuman_H.stockholm\nhuman_K.stockholm\nhuman_L.stockholm\nmouse_A.stockholm\nmouse_B.stockholm\nmouse_D.stockholm\nmouse_G.stockholm\nmouse_H.stockholm\nmouse_K.stockholm\nmouse_L.stockholm\npig_H.stockholm\npig_K.stockholm\npig_L.stockholm\nrabbit_H.stockholm\nrabbit_K.stockholm\nrabbit_L.stockholm\nrat_K.stockholm\nrat_L.stockholm\nrhesus_H.stockholm\nrhesus_K.stockholm\nrhesus_L.stockholm\n\n./ANARCI/build_pipeline/muscle_alignments:\nall_js.fasta\nall_js_aligned.fasta\n\n./ANARCI/lib:\npython\n\n./ANARCI/lib/python:\nanarci\n\n./ANARCI/lib/python/anarci:\n__init__.py\n__pycache__\nanarci.py\nschemes.py\n\n./ANARCI/lib/python/anarci/__pycache__:\n__init__.cpython-311.pyc\nanarci.cpython-311.pyc\nschemes.cpython-311.pyc\n\n./assistant:\n__init__.py\n__pycache__\nagent\nbiorxiv_scripts\ncommons\nenv_desc_biodatalab.py\nenv_desc_biomni.py\ninterface.py\nllm.py\nmodel\nprompts\ntask\ntool_biodatalab\ntool_biomni\nutils.py\nversion.py\n\n./assistant/__pycache__:\n__init__.cpython-311.pyc\n__init__.cpython-312.pyc\nenv_desc.cpython-311.pyc\nenv_desc_biodatalab.cpython-311.pyc\nllm.cpython-311.pyc\nutils.cpython-311.pyc\nversion.cpython-311.pyc\nversion.cpython-312.pyc\n\n./assistant/agent:\n__init__.py\n__pycache__\na1.py\na1_ref.py\ncost_count.py\nenv_collection.py\nqa_llm.py\nreact.py\n\n./assistant/agent/__pycache__:\n__init__.cpython-311.pyc\n__init__.cpython-312.pyc\na1.cpython-311.pyc\na1.cpython-312.pyc\na1_ref.cpython-311.pyc\ncost_count.cpython-311.pyc\n\n./assistant/biorxiv_scripts:\nextract_biorxiv_tasks.py\ngenerate_function.py\ngeneration_tools_all_subjects.py\nprocess_all_subjects.py\n\n./assistant/commons:\n__pycache__\nutils.py\n\n./assistant/commons/__pycache__:\nutils.cpython-311.pyc\n\n./assistant/model:\n__init__.py\n__pycache__\nretriever_biodatalab.py\nretriever_biomni.py\n\n./assistant/model/__pycache__:\n__init__.cpython-311.pyc\nretriever.cpython-311.pyc\nretriever_biodatalab.cpython-311.pyc\n\n./assistant/prompts:\nhelp_create_benchmark_task.txt\nhelp_summary_one_paper_database_and_tools.txt\nprompt.md\nsummary_domain_database_and_tools.txt\nsummary_domain_database_and_tools_merge.txt\n\n./assistant/task:\n__init__.py\n__pycache__\nbase_task.py\nhle.py\nlab_bench.py\n\n./assistant/task/__pycache__:\n__init__.cpython-311.pyc\n\n./assistant/tool_biodatalab:\n__pycache__\ndatabase.py\ndatabase_tools.py\nstructure_tools.py\nsupport_tools.py\ntool_description\ntool_registry.py\n\n./assistant/tool_biodatalab/__pycache__:\ndatabase.cpython-311.pyc\ndatabase_tools.cpython-311.pyc\nstructure_tools.cpython-311.pyc\nsupport_tools.cpython-311.pyc\ntool_registry.cpython-311.pyc\n\n./assistant/tool_biodatalab/tool_description:\n__pycache__\ndatabase.py\ndatabase_tools.py\nstructure_tools.py\nsupport_tools.py\n\n./assistant/tool_biodatalab/tool_description/__pycache__:\nsupport_tools.cpython-311.pyc\n\n./assistant/tool_biomni:\n__init__.py\n__pycache__\nbiochemistry.py\nbioengineering.py\nbiophysics.py\ncancer_biology.py\ncell_biology.py\ndatabase.py\nexample_mcp_tools\ngenetics.py\ngenomics.py\nimmunology.py\nliterature.py\nmicrobiology.py\nmolecular_biology.py\npathology.py\npharmacology.py\nphysiology.py\nschema_db\nsupport_tools.py\nsynthetic_biology.py\nsystems_biology.py\ntool_description\ntool_registry.py\n\n./assistant/tool_biomni/__pycache__:\n__init__.cpython-311.pyc\ndatabase.cpython-311.pyc\nliterature.cpython-311.pyc\nsupport_tools.cpython-311.pyc\ntool_registry.cpython-311.pyc\n\n./assistant/tool_biomni/example_mcp_tools:\npubmed_mcp.py\n\n./assistant/tool_biomni/schema_db:\ncbioportal.pkl\nclinvar.pkl\ndbsnp.pkl\nemdb.pkl\nensembl.pkl\ngeo.pkl\ngnomad.pkl\ngtopdb.pkl\ngwas_catalog.pkl\ninterpro.pkl\niucn.pkl\njaspar.pkl\nkegg.pkl\nmonarch.pkl\nmpd.pkl\nopenfda.pkl\nopentarget.pkl\nopentarget_genetics.pkl\npaleobiology.pkl\npdb.pkl\npride.pkl\nreactome.pkl\nremap.pkl\nstringdb.pkl\nucsc.pkl\nuniprot.pkl\nworms.pkl\n\n./assistant/tool_biomni/tool_description:\n__pycache__\nbiochemistry.py\nbioengineering.py\nbiophysics.py\ncancer_biology.py\ncell_biology.py\ndatabase.py\ngenetics.py\ngenomics.py\nimmunology.py\nliterature.py\nmicrobiology.py\nmolecular_biology.py\npathology.py\npharmacology.py\nphysiology.py\nsupport_tools.py\nsynthetic_biology.py\nsystems_biology.py\n\n./assistant/tool_biomni/tool_description/__pycache__:\nbiochemistry.cpython-311.pyc\nbioengineering.cpython-311.pyc\nbiophysics.cpython-311.pyc\ncancer_biology.cpython-311.pyc\ncell_biology.cpython-311.pyc\ndatabase.cpython-311.pyc\ngenetics.cpython-311.pyc\ngenomics.cpython-311.pyc\nimmunology.cpython-311.pyc\nliterature.cpython-311.pyc\nmicrobiology.cpython-311.pyc\nmolecular_biology.cpython-311.pyc\npathology.cpython-311.pyc\npharmacology.cpython-311.pyc\nphysiology.cpython-311.pyc\nsupport_tools.cpython-311.pyc\nsynthetic_biology.cpython-311.pyc\nsystems_biology.cpython-311.pyc\n\n./benchmark:\nREADME.md\nbiodatalab.csv\nbiodatalab_new.csv\ndataset\ngold_programs\ngold_results\ntasks\nupdate_verified_tasks.py\nverified_task.json\nverifiers\n\n./benchmark/dataset:\nADCdb\nASMdb\nATLAS\nBioKA\nCOLOCdb\nCOVID-19\nCancerMIRNome\nCancerProteome\nCancerSCEM\nCellCommuNet\nCellSTAR\nClinicalOmicsDB\nCompoDynamics\nCovPD</observation>"
        },
        {
            "role": "assistant",
            "content": "The previous `ls -R` output revealed the path `benchmark/dataset/ADCdb`. I will check if the PDF files are in `benchmark/dataset/ADCdb`.\n\n<execute>\n#!BASH\nls -F benchmark/dataset/ADCdb</execute>"
        },
        {
            "role": "user",
            "content": "<observation>ref2.pdf\nref4.pdf\nref5.pdf\n</observation>"
        },
        {
            "role": "assistant",
            "content": "The files are located in `benchmark/dataset/ADCdb`. I will update the file paths in my plan and proceed with the text extraction.\n\n### Updated Plan\n1. [\u2713] Create the temporary directory `/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/` and the output directory `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/`.\n2. [\u2713] Verify the existence of the input PDF files. (Found at `benchmark/dataset/ADCdb/ref2.pdf`, `benchmark/dataset/ADCdb/ref4.pdf`, `benchmark/dataset/ADCdb/ref5.pdf`)\n3. [ ] Extract text from each PDF file (`ref2.pdf`, `ref4.pdf`, `ref5.pdf`) using `pdfplumber`.\n4. [ ] Analyze the extracted text for each file to identify the required fields: `ADC Name`, `mAb`, `Linker`, `Payload`, `Conjugate Type`, `DAR`, `Drug Status`. I will perform a keyword-based extraction and print the text to manually refine the extraction logic if needed, or implement a heuristic rule-based extraction script.\n5. [ ] Consolidate the extracted data into a pandas DataFrame.\n6. [ ] Save the DataFrame as a CSV file to `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv`.\n\nNow I will extract the text from the PDFs.\n\n<execute>\nimport pdfplumber\nimport os\n\npdf_dir = \"benchmark/dataset/ADCdb\"\npdf_files = [\"ref2.pdf\", \"ref4.pdf\", \"ref5.pdf\"]\noutput_dir = \"/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/\"\n\nextracted_texts = {}\n\nfor pdf_file in pdf_files:\n    pdf_path = os.path.join(pdf_dir, pdf_file)\n    print(f\"Extracting text from {pdf_path}...\")\n    try:\n        with pdfplumber.open(pdf_path) as pdf:\n            text = \"\"\n            for page in pdf.pages:\n                text += page.extract_text() + \"\\n\"\n            extracted_texts[pdf_file] = text\n            # Save raw text for inspection\n            with open(os.path.join(output_dir, f\"{pdf_file}.txt\"), \"w\") as f:\n                f.write(text)\n    except Exception as e:\n        print(f\"Error extracting {pdf_file}: {e}\")\n\n# Print the first 1000 characters of each extracted text to get an idea of the content\nfor pdf_file, text in extracted_texts.items():\n    print(f\"--- {pdf_file} ---\")\n    print(text[:1000])\n    print(\"\\n\" + \"=\"*50 + \"\\n\")</execute>"
        },
        {
            "role": "user",
            "content": "<observation>Extracting text from benchmark/dataset/ADCdb/ref2.pdf...\nExtracting text from benchmark/dataset/ADCdb/ref4.pdf...\nExtracting text from benchmark/dataset/ADCdb/ref5.pdf...\n--- ref2.pdf ---\nHEMATOLOGIC MALIGNANCIES\u2014LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA\nTPS7589 Poster Session\nwaveLINE-007: Phase 2 study of zilovertamab vedotin (ZV) in combination with cyclo-\nphosphamide,doxorubicin,andprednisoneplusrituximab(R-CHP)inpreviouslyuntreated\ndiffuse large B-cell lymphoma (DLBCL).\nDavid Lavie, Muhit Ozcan, Ewa Paszkiewicz-Kozik, Eva Gonza\u00b4lez Barca, Tae Min Kim,\nBenedettaPuccini,SiruoWang,RushdiaYusuf,PatriciaMarinello,WonSeogKim;HadassahMedical\nCenter,Jerusalem,Israel;AnkaraUniversitySchoolofMedicine,Ankara,Turkey;MariaSklodowska-\nCurieNationalResearchInstituteofOncology,Warsaw,Poland;InstitutCatala` d\u2019OncologiaHospitalet,\nBarcelona University, IDIBELL, Barcelona, Spain; Seoul National University Hospital, Seoul, South\nKorea; Unit AOU Careggi, Florence, Italy; Merck & Co., Inc., Rahway, NJ; Samsung Medical Center,\nSeoul, South Korea\nBackground:Thepreferredfirst-lineregimenforDLBCLisrituximabwithcyclophosphamide,doxoru-\nbicin,vincristine,andprednisone(R-CHOP);butnoveltherapie\n\n==================================================\n\n--- ref4.pdf ---\nDEVELOPMENTAL THERAPEUTICS\u2014MOLECULARLYTARGETEDAGENTSAND TUMOR BIOLOGY\n3001 Oral Abstract Session\nBL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in pa-\ntientswithlocallyadvancedormetastaticsolidtumor:Resultsfromafirst-in-humanphase\n1 study.\nLi Zhang, Yuxiang Ma, Yuanyuan Zhao, Wenfeng Fang, Hongyun Zhao, Yan Huang, Yunpeng Yang,\nLikun Chen, Xue Hou, Wen Zou, Muran Ding, Jing Yu, Suoyu Zhang, Junxian Wang, Sa Xiao,\nHongwei Wang, Hai Zhu, Martin Sebastian Olivo, Yi Zhu; Department of Medical Oncology, State\nKeyLaboratoryofOncologyinSouthChina;CollaborativeInnovationCenterforCancerMedicine,Sun\nYat-sen University Cancer Center, Guangzhou, Guangdong, China; Department of Clinical Research,\nSunYat-senUniversityCancerCenter,StateKeyLaboratoryofOncologyinSouthChina,Collaborative\nInnovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma\nDiagnosis and Therapy, Guangz, Guangzhou, China; Department of Medical Oncology, Sun Yat-sen\nUn\n\n==================================================\n\n--- ref5.pdf ---\nHEMATOLOGIC MALIGNANCIES\u2014LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA\nTPS7595 Poster Session\nwaveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as\nmonotherapy or in combination in patients (pts) with aggressive and indolent B-cell\nmalignancies.\nPierLuigiZinzani,JiriMayer,OhadBenjamini,AlejandroBerkovits,IngridGlimelius,DonA.Stevens,\nArvindChaudhry,AhmetMuzafferDemir,Ramo\u00b4nGarciaSanz,WonSeogKim,FeiLi,JanuszHalka,\nAna Marin-Niebla, Muhit Ozcan, Ewa Paszkiewicz-Kozik, Armando Santoro, Yixin Ren, Uzor Ogbu,\nPatriciaMarinello,WojciechJurczak;IRCCSAziendaOspedaliero-UniversitariadiBolognaIstitutodi\nEmatologia\u201cSera`gnoli\u201d,Bologna,Italy;FakultniNemocniceBrnoBohunice-InterniHematologickaa\nOnkologicka Klinika, Brno, Czech Republic; Chaim Sheba Medical Center, Ramat Gan, Israel;\nInmunocel Chile, Santiago, Chile; Uppsala University and Akademiska sjukhuset-Blod-och tumor-\nsjukdomar,Uppsala,Sweden;NortonWomen\u2019sandChildren\u2019sHospital\u2013NortonCancerInstitute\u2013St.\nMatthews, Loui\n\n==================================================\n\n</observation>"
        },
        {
            "role": "assistant",
            "content": "Based on the extracted text, I can identify the following information:\n\n**ref2.pdf:**\n*   **ADC Name**: zilovertamab vedotin (ZV)\n*   **Drug Status**: Phase 2 (mentioned in title: \"Phase 2 study of zilovertamab vedotin...\")\n*   **mAb**: Not explicitly clear in the snippet, but \"zilovertamab\" implies the antibody part. I need to check the full text for \"mAb\" or \"antibody\" details.\n*   **Linker**: Need to search for \"linker\".\n*   **Payload**: \"vedotin\" usually implies MMAE (monomethyl auristatin E). Need to confirm.\n*   **Conjugate Type**: Need to search.\n*   **DAR**: Need to search.\n\n**ref4.pdf:**\n*   **ADC Name**: BL-B01D1\n*   **mAb**: EGFRxHER3 bispecific antibody (mentioned in title).\n*   **Drug Status**: Phase 1 (mentioned in title: \"Results from a first-in-human phase 1 study\").\n*   **Linker**: Need to search.\n*   **Payload**: Need to search.\n*   **Conjugate Type**: Need to search.\n*   **DAR**: Need to search.\n\n**ref5.pdf:**\n*   **ADC Name**: zilovertamab vedotin\n*   **Drug Status**: Phase 2 (mentioned in title: \"waveLINE-006: A phase 2 study...\").\n*   **mAb**: Zilovertamab.\n*   **Linker**: Need to search.\n*   **Payload**: Need to search.\n*   **Conjugate Type**: Need to search.\n*   **DAR**: Need to search.\n\nIt seems \"zilovertamab vedotin\" is the subject of both ref2 and ref5. \"vedotin\" typically refers to the linker-payload mc-val-cit-PABC-MMAE, but I should verify if the text explicitly states the linker and payload.\n\nFor \"BL-B01D1\", I need to dig deeper.\n\nI will write a script to search for specific keywords (\"linker\", \"payload\", \"conjugation\", \"DAR\", \"ratio\", \"antibody\", \"IgG\", \"MMAE\", \"MMAF\", \"exatecan\", \"deruxtecan\", etc.) in the full text of each PDF to fill in the missing details.\n\n<execute>\nimport re\n\nextracted_texts = {}\npdf_files = [\"ref2.pdf\", \"ref4.pdf\", \"ref5.pdf\"]\noutput_dir = \"/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/\"\n\nfor pdf_file in pdf_files:\n    with open(os.path.join(output_dir, f\"{pdf_file}.txt\"), \"r\") as f:\n        extracted_texts[pdf_file] = f.read()\n\nkeywords = [\"linker\", \"payload\", \"conjugat\", \"DAR\", \"ratio\", \"antibody\", \"IgG\", \"drug\", \"status\", \"phase\", \"MMAE\", \"MMAF\", \"topoisomerase\", \"auristatin\", \"maytansinoid\", \"cleavable\", \"cysteine\", \"lysine\"]\n\nfor pdf_file, text in extracted_texts.items():\n    print(f\"--- Analysis for {pdf_file} ---\")\n    \n    # Simple context extraction for keywords\n    for keyword in keywords:\n        matches = re.finditer(keyword, text, re.IGNORECASE)\n        for match in matches:\n            start = max(0, match.start() - 50)\n            end = min(len(text), match.end() + 50)\n            print(f\"[{keyword}]: ...{text[start:end].replace(chr(10), ' ')}...\")\n    print(\"\\n\")</execute>"
        },
        {
            "role": "user",
            "content": "<observation>NameError(\"name 'os' is not defined\")</observation>"
        },
        {
            "role": "assistant",
            "content": "I forgot to import `os` in the previous block. I will correct this and run the keyword search again.\n\n<execute>\nimport re\nimport os\n\npdf_files = [\"ref2.pdf\", \"ref4.pdf\", \"ref5.pdf\"]\noutput_dir = \"/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/\"\nextracted_texts = {}\n\nfor pdf_file in pdf_files:\n    try:\n        with open(os.path.join(output_dir, f\"{pdf_file}.txt\"), \"r\") as f:\n            extracted_texts[pdf_file] = f.read()\n    except FileNotFoundError:\n        print(f\"File {pdf_file}.txt not found.\")\n        continue\n\nkeywords = [\"linker\", \"payload\", \"conjugat\", \"DAR\", \"ratio\", \"antibody\", \"IgG\", \"drug\", \"status\", \"phase\", \"MMAE\", \"MMAF\", \"topoisomerase\", \"auristatin\", \"maytansinoid\", \"cleavable\", \"cysteine\", \"lysine\", \"ED-04\", \"topoisomerase I inhibitor\"]\n\nfor pdf_file, text in extracted_texts.items():\n    print(f\"--- Analysis for {pdf_file} ---\")\n    \n    # Simple context extraction for keywords\n    # Limit to first 5 matches per keyword to avoid flooding output\n    for keyword in keywords:\n        matches = list(re.finditer(keyword, text, re.IGNORECASE))\n        if matches:\n            print(f\"Found {len(matches)} matches for '{keyword}'\")\n            for i, match in enumerate(matches[:5]): # Show up to 5 contexts\n                start = max(0, match.start() - 100)\n                end = min(len(text), match.end() + 100)\n                # Clean up newlines for better readability\n                context = text[start:end].replace('\\n', ' ').strip()\n                print(f\"  Match {i+1}: ...{context}...\")\n    print(\"\\n\")</execute>"
        },
        {
            "role": "user",
            "content": "<observation>--- Analysis for ref2.pdf ---\nFound 1 matches for 'linker'\n  Match 1: ...overexpressedinDLBCL.ZVisan ADCcomprisingahumanizedIgG1monoclonalanti-ROR1,aproteolyticallycleavablelinker,andthe antimicrotubuleagent,monomethylauristatinE.Thesingle-arm,open-label,phase2waveLINE-007 study...\nFound 1 matches for 'conjugat'\n  Match 1: ...HOP);butnoveltherapiesareneeded.Arecentphase3study showedthatreplacingvincristinewithanantibody-drugconjugate(ADC)isaviableapproach(TillyH etal.NEnglJMed.2022;386:351-363).Receptortyrosinekinase\u2013likeorphanrec...\nFound 1 matches for 'DAR'\n  Match 1: ...th R-CHP, and complete response rate per Lugano 2014 criteria as assessed by the investigator. Secondary end points are objective response rate and duration of response per Lugano 2014 criteria by invest...\nFound 1 matches for 'ratio'\n  Match 1: ...14 criteria as assessed by the investigator. Secondary end points are objective response rate and duration of response per Lugano 2014 criteria by investigator review. Exploratoryendpointsincludeprogressio...\nFound 1 matches for 'antibody'\n  Match 1: ...rednisone(R-CHOP);butnoveltherapiesareneeded.Arecentphase3study showedthatreplacingvincristinewithanantibody-drugconjugate(ADC)isaviableapproach(TillyH etal.NEnglJMed.2022;386:351-363).Receptortyrosinekinase\u2013...\nFound 1 matches for 'IgG'\n  Match 1: ...lproteinthatisminimallyexpressedinadulttissuesandoverexpressedinDLBCL.ZVisan ADCcomprisingahumanizedIgG1monoclonalanti-ROR1,aproteolyticallycleavablelinker,andthe antimicrotubuleagent,monomethylauristati...\nFound 1 matches for 'drug'\n  Match 1: ...(R-CHOP);butnoveltherapiesareneeded.Arecentphase3study showedthatreplacingvincristinewithanantibody-drugconjugate(ADC)isaviableapproach(TillyH etal.NEnglJMed.2022;386:351-363).Receptortyrosinekinase\u2013likeo...\nFound 4 matches for 'phase'\n  Match 1: ...TOLOGIC MALIGNANCIES\u2014LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA TPS7589 Poster Session waveLINE-007: Phase 2 study of zilovertamab vedotin (ZV) in combination with cyclo- phosphamide,doxorubicin,andpredniso...\n  Match 2: ...hcyclophosphamide,doxoru- bicin,vincristine,andprednisone(R-CHOP);butnoveltherapiesareneeded.Arecentphase3study showedthatreplacingvincristinewithanantibody-drugconjugate(ADC)isaviableapproach(TillyH etal....\n  Match 3: ...lyticallycleavablelinker,andthe antimicrotubuleagent,monomethylauristatinE.Thesingle-arm,open-label,phase2waveLINE-007 study(NCT05406401)willinvestigateZVcombinedwithR-CHPinpatientswithpreviouslyuntreated...\n  Match 4: ...ntswithpreviouslyuntreated DLBCL.Part1isbeingconductedtodeterminesafetyandtolerabilityandrecommendedphase2dose (RP2D)ofZVincombinationwithR-CHP.Part2willbeconductedtoinvestigateefficacyofZVatthe RP2DwithR-...\nFound 1 matches for 'auristatin'\n  Match 1: ...anizedIgG1monoclonalanti-ROR1,aproteolyticallycleavablelinker,andthe antimicrotubuleagent,monomethylauristatinE.Thesingle-arm,open-label,phase2waveLINE-007 study(NCT05406401)willinvestigateZVcombinedwithR-CHPin...\nFound 1 matches for 'cleavable'\n  Match 1: ...issuesandoverexpressedinDLBCL.ZVisan ADCcomprisingahumanizedIgG1monoclonalanti-ROR1,aproteolyticallycleavablelinker,andthe antimicrotubuleagent,monomethylauristatinE.Thesingle-arm,open-label,phase2waveLINE-007...\n\n\n--- Analysis for ref4.pdf ---\nFound 1 matches for 'linker'\n  Match 1: ...ssnovelADCconsistingofanEGFRxHER3bispecificantibody linkedtoanovelTOP-Iinhibitorpayloadviaacleavablelinker.Wenowpresentsafety/efficacyresults from a FIH phase I study of BL-B01D1. Methods: This study includ...\nFound 1 matches for 'payload'\n  Match 1: ...B01D1isafirst-in-classnovelADCconsistingofanEGFRxHER3bispecificantibody linkedtoanovelTOP-Iinhibitorpayloadviaacleavablelinker.Wenowpresentsafety/efficacyresults from a FIH phase I study of BL-B01D1. Methods...\nFound 1 matches for 'conjugat'\n  Match 1: ...OR BIOLOGY 3001 Oral Abstract Session BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in pa- tientswithlocallyadvancedormetastaticsolidtumor:Resultsfromafirst-in-humanphase 1 st...\nFound 1 matches for 'ratio'\n  Match 1: ...%), decreased appetite (22%/ ,1%),asthenia(21%/,1%),hypophagia(16%/0%),diarrhoea(15%/2%), mouth ulceration (15%/ ,1%), rash (13%/0%). No ILD was observed. 122 pts were evaluable for efficacy (at least 1 tu...\nFound 2 matches for 'antibody'\n  Match 1: ...DAGENTSAND TUMOR BIOLOGY 3001 Oral Abstract Session BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in pa- tientswithlocallyadvancedormetastaticsolidtumor:Resultsfromafirst-in-h...\n  Match 2: ...ne, INC., Redmond, WA Background: BL-B01D1isafirst-in-classnovelADCconsistingofanEGFRxHER3bispecificantibody linkedtoanovelTOP-Iinhibitorpayloadviaacleavablelinker.Wenowpresentsafety/efficacyresults from a FI...\nFound 1 matches for 'drug'\n  Match 1: ...D TUMOR BIOLOGY 3001 Oral Abstract Session BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in pa- tientswithlocallyadvancedormetastaticsolidtumor:Resultsfromafirst-in-humanp...\nFound 2 matches for 'phase'\n  Match 1: ...g conjugate (ADC), in pa- tientswithlocallyadvancedormetastaticsolidtumor:Resultsfromafirst-in-humanphase 1 study. Li Zhang, Yuxiang Ma, Yuanyuan Zhao, Wenfeng Fang, Hongyun Zhao, Yan Huang, Yunpeng Yang,...\n  Match 2: ...inkedtoanovelTOP-Iinhibitorpayloadviaacleavablelinker.Wenowpresentsafety/efficacyresults from a FIH phase I study of BL-B01D1. Methods: This study included patients (pts) with locally advancedormetastatics...\nFound 1 matches for 'cleavable'\n  Match 1: ...st-in-classnovelADCconsistingofanEGFRxHER3bispecificantibody linkedtoanovelTOP-Iinhibitorpayloadviaacleavablelinker.Wenowpresentsafety/efficacyresults from a FIH phase I study of BL-B01D1. Methods: This study...\n\n\n--- Analysis for ref5.pdf ---\nFound 1 matches for 'linker'\n  Match 1: ...antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andtheantimicrotubuleagentmonomethylauristatinE.Nemtabrutinib isareversibleinhibitorofBrutonstyrosi...\nFound 1 matches for 'conjugat'\n  Match 1: ...ransmembraneproteinexpressedinhematologicmalignancies.Zilovertamab vedotin (ZV) is an antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andtheantimicro...\nFound 1 matches for 'DAR'\n  Match 1: ...eresponserateofZValone(cohortsA,B,D,E,andF)andincombination with nemtabrutinib (cohort C). The secondary end points are the duration of response of ZV alone (cohorts A, B, D, E, and F) and in combination...\nFound 1 matches for 'ratio'\n  Match 1: ...ortsA,B,D,E,andF)andincombination with nemtabrutinib (cohort C). The secondary end points are the duration of response of ZV alone (cohorts A, B, D, E, and F) and in combination with nemtabrutinib (cohort...\nFound 1 matches for 'antibody'\n  Match 1: ...round:ROR1isatransmembraneproteinexpressedinhematologicmalignancies.Zilovertamab vedotin (ZV) is an antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,a...\nFound 1 matches for 'IgG'\n  Match 1: ...atologicmalignancies.Zilovertamab vedotin (ZV) is an antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andtheantimicrotubuleagentmonomethylaurista...\nFound 1 matches for 'drug'\n  Match 1: ...1isatransmembraneproteinexpressedinhematologicmalignancies.Zilovertamab vedotin (ZV) is an antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andthe...\nFound 1 matches for 'status'\n  Match 1: ...leukemia (CLL), or follicular lymphoma (FL), relapsed or refractory (R/R) disease, ECOG performance status of 0 to 2, and adequate organ function (table). Approximately 275 pts will be enrolledin6cohorts(A-...\nFound 2 matches for 'phase'\n  Match 1: ...LOGIC MALIGNANCIES\u2014LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA TPS7595 Poster Session waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in pati...\n  Match 2: ...IncohortsAandB,patientswillreceiveZV2.5mg/kgIVQ3W.In cohortC,30patientswillbeenrolledinasafetyrun-inphaseofZVincombinationwithnemtabrutinib, thenanadditional15patientswillreceivetheRP2Dofthecombination.Pat...\nFound 1 matches for 'auristatin'\n  Match 1: ...zed IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andtheantimicrotubuleagentmonomethylauristatinE.Nemtabrutinib isareversibleinhibitorofBrutonstyrosinekinase(BTK).ThecombinationofZVandaBTKihasthe...\nFound 1 matches for 'cleavable'\n  Match 1: ...V) is an antibody-drug conjugate comprising a humanized IgG1 monoclonal anti-ROR1, a proteolyticallycleavablelinker,andtheantimicrotubuleagentmonomethylauristatinE.Nemtabrutinib isareversibleinhibitorofBrutons...\n\n\n</observation>"
        },
        {
            "role": "assistant",
            "content": "Based on the keyword analysis, I have the following information:\n\n**ref2.pdf:**\n*   **ADC Name**: zilovertamab vedotin (ZV)\n*   **mAb**: humanized IgG1 monoclonal anti-ROR1\n*   **Linker**: proteolytically cleavable linker\n*   **Payload**: monomethyl auristatin E (MMAE)\n*   **Conjugate Type**: N/A (Not explicitly mentioned in snippet, likely standard cysteine or lysine, but \"vedotin\" usually implies cysteine via maleimide, but the text doesn't confirm it).\n*   **DAR**: N/A (Text mentions \"duration of response\" not Drug-Antibody Ratio).\n*   **Drug Status**: Phase 2\n\n**ref4.pdf:**\n*   **ADC Name**: BL-B01D1\n*   **mAb**: EGFRxHER3 bispecific antibody\n*   **Linker**: cleavable linker\n*   **Payload**: novel TOP-I inhibitor (Ed-04 payload often used with this company, but text says \"novel TOP-I inhibitor payload\"). I will stick to \"novel TOP-I inhibitor\" unless I find a specific name.\n*   **Conjugate Type**: N/A (Not explicitly mentioned).\n*   **DAR**: N/A.\n*   **Drug Status**: Phase 1\n\n**ref5.pdf:**\n*   **ADC Name**: zilovertamab vedotin (ZV)\n*   **mAb**: humanized IgG1 monoclonal anti-ROR1\n*   **Linker**: proteolytically cleavable linker\n*   **Payload**: monomethyl auristatin E\n*   **Conjugate Type**: N/A.\n*   **DAR**: N/A.\n*   **Drug Status**: Phase 2\n\nI need to confirm if there are any mentions of \"DAR\" or specific numbers related to drug loading. I'll search specifically for digits near \"DAR\" or \"ratio\". Also, I will look for specific chemical names for the payload in ref4 if possible.\n\nOne detail to refine: \"proteolytically cleavable linker\" is a description. The specific name might be \"mc-val-cit-PABC\" implied by \"vedotin\", but the text explicitly says \"proteolytically cleavable linker\". I will use the text description \"Proteolytically cleavable linker\".\n\nFor Ref 4 payload: \"novel TOP-I inhibitor payload\". I'll check if \"Ed-04\" appears in the full text of ref4.\n\nLet's do a more targeted search for DAR and specific payload names.\n\n<execute>\nimport re\nimport os\n\npdf_files = [\"ref2.pdf\", \"ref4.pdf\", \"ref5.pdf\"]\noutput_dir = \"/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/\"\nextracted_texts = {}\n\nfor pdf_file in pdf_files:\n    try:\n        with open(os.path.join(output_dir, f\"{pdf_file}.txt\"), \"r\") as f:\n            extracted_texts[pdf_file] = f.read()\n    except FileNotFoundError:\n        continue\n\nspecial_keywords = [\"Ed-04\", \"topoisomerase\", \"camptothecin\", \"DXd\", \"SN-38\", \"MMAE\", \"vc-MMAE\", \"mc-MMAE\"]\n\nfor pdf_file, text in extracted_texts.items():\n    print(f\"--- Analysis for {pdf_file} ---\")\n    \n    # Check for DAR specifically with numbers\n    dar_matches = re.findall(r\"DAR\\s*[:=]?\\s*(\\d+(?:\\.\\d+)?)\", text, re.IGNORECASE)\n    if dar_matches:\n        print(f\"DAR matches found: {dar_matches}\")\n    else:\n        # Check for \"drug-to-antibody ratio\" phrases\n        ratio_matches = re.findall(r\"drug-to-antibody ratio.*?(\\d+(?:\\.\\d+)?)\", text, re.IGNORECASE)\n        if ratio_matches:\n            print(f\"Ratio matches found: {ratio_matches}\")\n        else:\n             print(\"No DAR/Ratio matches found.\")\n\n    for keyword in special_keywords:\n        if keyword.lower() in text.lower():\n             print(f\"Found specific keyword: {keyword}\")\n\n    print(\"\\n\")</execute>"
        },
        {
            "role": "user",
            "content": "<observation>--- Analysis for ref2.pdf ---\nNo DAR/Ratio matches found.\n\n\n--- Analysis for ref4.pdf ---\nNo DAR/Ratio matches found.\n\n\n--- Analysis for ref5.pdf ---\nNo DAR/Ratio matches found.\n\n\n</observation>"
        },
        {
            "role": "assistant",
            "content": "Since no explicit DAR is found in the text for any of the papers, I will mark DAR as \"N/A\".\nFor ref4, the payload is described as \"novel TOP-I inhibitor\", and no specific name like \"Ed-04\" was found.\n\nLet's double check the \"Conjugate Type\". Common types are \"Lysine\", \"Cysteine\", \"Site-specific\". If not mentioned, I will put \"N/A\".\n\nI have enough information to construct the final CSV.\n\n**Summary of Extraction:**\n\n| Paper | ADC Name | mAb | Linker | Payload | Conjugate Type | DAR | Drug Status |\n| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |\n| ref2 | zilovertamab vedotin | humanized IgG1 monoclonal anti-ROR1 | proteolytically cleavable linker | monomethyl auristatin E | N/A | N/A | Phase 2 |\n| ref4 | BL-B01D1 | EGFRxHER3 bispecific antibody | cleavable linker | novel TOP-I inhibitor | N/A | N/A | Phase 1 |\n| ref5 | zilovertamab vedotin | humanized IgG1 monoclonal anti-ROR1 | proteolytically cleavable linker | monomethyl auristatin E | N/A | N/A | Phase 2 |\n\nI'll refine the entries slightly for consistency.\n- ref2/ref5 mAb: \"Anti-ROR1 IgG1\" or \"Humanized IgG1 monoclonal anti-ROR1\". The example uses \"Anti-Target-Y IgG1\", so \"Anti-ROR1 IgG1\" is a good concise format, but \"Humanized IgG1 monoclonal anti-ROR1\" is more accurate to the text. I will use the text extracted: \"Humanized IgG1 monoclonal anti-ROR1\".\n- ref4 mAb: \"EGFRxHER3 bispecific antibody\".\n- ref2/ref5 Linker: \"Proteolytically cleavable linker\".\n- ref4 Linker: \"Cleavable linker\".\n- ref2/ref5 Payload: \"Monomethyl auristatin E\".\n- ref4 Payload: \"Novel TOP-I inhibitor\".\n- Status: \"Phase 2\" for ref2/ref5, \"Phase 1\" for ref4.\n\nWait, for ref2/ref5, \"vedotin\" implies \"MMAE\" linked via \"mc-val-cit-PABC\". The text confirms \"proteolytically cleavable linker\" and \"monomethyl auristatin E\".\nFor \"Conjugate Type\", vedotin ADCs (like Polivy, Padcev) usually use Cysteine conjugation (reduction of interchain disulfides). However, without explicit mention in the text, I should stick to \"N/A\" or \"N/A\" to be safe, as \"Conjugate Type\" often refers to site-specific vs stochastic. The example shows \"Cysteine conjugation\" or \"Site-specific\". Since I didn't find these keywords associated with the ADC description, \"N/A\" is the most honest answer based on the provided text.\n\nOne last check on ref4: \"BL-B01D1\". Is there any mention of \"cysteine\" or \"lysine\"?\nIn my keyword search, \"cysteine\" and \"lysine\" were keywords. Let's look at the output again.\nRef2/4/5 analysis didn't show matches for \"cysteine\" or \"lysine\" in the snippet view.\n\nI will finalize the DataFrame creation and saving.\n\n### Updated Plan\n1. [\u2713] Create the temporary directory `/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/` and the output directory `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/`.\n2. [\u2713] Verify the existence of the input PDF files.\n3. [\u2713] Extract text from each PDF file.\n4. [\u2713] Analyze the extracted text for each file to identify the required fields.\n5. [ ] Consolidate the extracted data into a pandas DataFrame.\n6. [ ] Save the DataFrame as a CSV file to `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv`.\n\n<execute>\nimport pandas as pd\nimport os\n\ndata = [\n    {\n        \"Paper\": \"ref2\",\n        \"ADC Name\": \"zilovertamab vedotin\",\n        \"mAb\": \"Humanized IgG1 monoclonal anti-ROR1\",\n        \"Linker\": \"Proteolytically cleavable linker\",\n        \"Payload\": \"Monomethyl auristatin E\",\n        \"Conjugate Type\": \"N/A\",\n        \"DAR\": \"N/A\",\n        \"Drug Status\": \"Phase 2\"\n    },\n    {\n        \"Paper\": \"ref4\",\n        \"ADC Name\": \"BL-B01D1\",\n        \"mAb\": \"EGFRxHER3 bispecific antibody\",\n        \"Linker\": \"Cleavable linker\",\n        \"Payload\": \"Novel TOP-I inhibitor\",\n        \"Conjugate Type\": \"N/A\",\n        \"DAR\": \"N/A\",\n        \"Drug Status\": \"Phase 1\"\n    },\n    {\n        \"Paper\": \"ref5\",\n        \"ADC Name\": \"zilovertamab vedotin\",\n        \"mAb\": \"Humanized IgG1 monoclonal anti-ROR1\",\n        \"Linker\": \"Proteolytically cleavable linker\",\n        \"Payload\": \"Monomethyl auristatin E\",\n        \"Conjugate Type\": \"N/A\",\n        \"DAR\": \"N/A\",\n        \"Drug Status\": \"Phase 2\"\n    }\n]\n\ndf = pd.DataFrame(data)\n\noutput_path = \"/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv\"\ndf.to_csv(output_path, index=False)\n\nprint(f\"Data saved to {output_path}\")\nprint(df)</execute>"
        },
        {
            "role": "user",
            "content": "<observation>Data saved to /root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv\n  Paper              ADC Name  ...  DAR Drug Status\n0  ref2  zilovertamab vedotin  ...  N/A     Phase 2\n1  ref4              BL-B01D1  ...  N/A     Phase 1\n2  ref5  zilovertamab vedotin  ...  N/A     Phase 2\n\n[3 rows x 8 columns]\n</observation>"
        },
        {
            "role": "assistant",
            "content": "I have successfully extracted the information and saved it to the specified CSV file.\n\n### Final Plan Status\n1. [\u2713] Create the temporary directory `/root/autodl-tmp/biomni_v20260208_tmp/gemini-3-pro-preview/adcdb_extract/` and the output directory `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/`.\n2. [\u2713] Verify the existence of the input PDF files.\n3. [\u2713] Extract text from each PDF file.\n4. [\u2713] Analyze the extracted text for each file to identify the required fields.\n5. [\u2713] Consolidate the extracted data into a pandas DataFrame.\n6. [\u2713] Save the DataFrame as a CSV file to `/root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv`.\n\nThe task is complete.\n\n<solution> /root/autodl-tmp/biomni_v20260208_pred_results/gemini-3-pro-preview/adcdb_extract_1.csv </solution>"
        }
    ]
}